Regenerative Medical Technology Group Inc.
RMTG
$0.0486
$0.020975.45%
| Weiss Ratings | RMTG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | RMTG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | RMTG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -1.19 | |||
| Price History | RMTG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 111.30% | |||
| 30-Day Total Return | 76.73% | |||
| 60-Day Total Return | 3.40% | |||
| 90-Day Total Return | 1.25% | |||
| Year to Date Total Return | 70.53% | |||
| 1-Year Total Return | 3.18% | |||
| 2-Year Total Return | 94.40% | |||
| 3-Year Total Return | -62.62% | |||
| 5-Year Total Return | 301.65% | |||
| 52-Week High % Change | -35.20% | |||
| 52-Week Low % Change | 134.78% | |||
| Price | RMTG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.08 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Jun 17, 2024 | |||
| 52-Week High Price (Date) | Aug 05, 2024 | |||
| Valuation | RMTG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 609.39K | |||
| Enterprise Value | 19.63M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.42 | |||
| Earnings Per Share Growth | -51.18% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.19 | |||
| Price/Book (Q) | -0.02 | |||
| Enterprise Value/Revenue (TTM) | 6.11 | |||
| Price | $0.05 | |||
| Enterprise Value/EBITDA (TTM) | -529.23 | |||
| Enterprise Value/EBIT | -51.35 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | RMTG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 12.54M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | RMTG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 800 956 3935 | |||
| Address | 433 Plaza Real Boca Raton, FL 33432 | |||
| Website | regenmedtechgroup.com | |||
| Country | United States | |||
| Year Founded | 1999 | |||
| Profitability | RMTG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -11.90% | |||
| Profit Margin | -161.28% | |||
| Management Effectiveness | RMTG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -7.31% | |||
| Return on Equity | -- | |||
| Income Statement | RMTG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.21M | |||
| Total Revenue (TTM) | 3.21M | |||
| Revenue Per Share | $0.26 | |||
| Gross Profit (TTM) | 2.28M | |||
| EBITDA (TTM) | -37.10K | |||
| EBIT (TTM) | -382.40K | |||
| Net Income (TTM) | -5.18M | |||
| Net Income Avl. to Common (TTM) | -5.18M | |||
| Total Revenue Growth (Q YOY) | 52.49% | |||
| Earnings Growth (Q YOY) | 84.85% | |||
| EPS Diluted (TTM) | -0.42 | |||
| EPS Diluted Growth (Q YOY) | 84.96% | |||
| Balance Sheet | RMTG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 836.40K | |||
| Cash Per Share (Q) | $0.07 | |||
| Total Current Assets (Q) | 917.20K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -26.72M | |||
| Current Ratio (Q) | 0.033 | |||
| Book Value Per Share (Q) | -$2.13 | |||
| Total Assets (Q) | 3.23M | |||
| Total Current Liabilities (Q) | 27.49M | |||
| Total Debt (Q) | 19.86M | |||
| Total Liabilities (Q) | 29.95M | |||
| Total Common Equity (Q) | -26.72M | |||
| Cash Flow | RMTG - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -449.50K | |||
| Cash from Financing (TTM) | -300.00K | |||
| Net Change in Cash (TTM) | -307.60K | |||
| Levered Free Cash Flow (TTM) | 1.23M | |||
| Cash from Operations (TTM) | 441.90K | |||
